Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Which definition to use when defining reversibility of airway obstruction?
Revue des Maladies Respiratoires, Volume 24, No. 9, Year 2007
Notification
URL copied to clipboard!
Description
Introduction: There is no clear consensus about what constitutes reversibility of airway obstruction. European Respiratory Society (ERS): Increase in FEV1 and/or FVC > 12% of their theoretical value and > 0.2l. British Thoracic Society: FEV1 >15% of initial value and FEV1 > 0.2l. Global Initiative for Chronic Obstructive Lung Disease: Increase in FEV1 > 12% and > 0.2l. Australia and New Zealand Thoracic Society: Increase in FEV1 > 15%. American Thoracic Society/ERS: Increase in FEV1 > 12% and > 0.2l or increase in FVC > 12% and 0.2l. Our principal objective was to determine the percentage of patients with COPD (n = 62) who were significant responders to the reversibility test according to the 5 recommendations. Methods: Plethysmography was performed before and 15 minutes after inhalation of 400 micrograms of a short acting bronchodilator (BD). COPD is defined as a FEV1/FVC post BD < 0.7. Results: The percentage of responders varied from 24% to 50% depending on the recommendations used. Conclusion: Reversibility of airway obstruction is recommendation dependent. © 2007 SPLF. Édité par Elsevier Masson SAS.
Authors & Co-Authors
Ben saad, Helmi
Tunisia, Sousse
Service de Physiologie et Des Explorations Fonctionnelles
Tunisia, Sousse
Faculty of Medicine Sousse
Ben Attia Saafi, R.
Tunisia, Sousse
Service de Physiologie et Des Explorations Fonctionnelles
Rouatbi, Sonia
Tunisia, Sousse
Service de Physiologie et Des Explorations Fonctionnelles
Ben Mdella, S.
Tunisia, Sousse
Service de Physiologie et Des Explorations Fonctionnelles
Garrouche, Abdelhamid
Tunisia, Sousse
Service de Pneumologie
Hadj Mtir, Abdelaziz
Tunisia, Sousse
Service de Physiologie et Des Explorations Fonctionnelles
Harrabi, Imed
Tunisia, Sousse
Service D'épidémiologie
Tabka, Zouhaïr
Tunisia, Sousse
Service de Physiologie et Des Explorations Fonctionnelles
Zbidi, Abdelkarim
Tunisia, Sousse
Service de Physiologie et Des Explorations Fonctionnelles
Statistics
Citations: 16
Authors: 9
Affiliations: 4
Identifiers
Doi:
10.1016/S0761-8425(07)74260-2
ISSN:
07618425
Research Areas
Noncommunicable Diseases